Literature DB >> 19270439

Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.

Karin Piehl-Aulin1, Ian Jones, Björn Lindvall, Anders Magnuson, Samy M Abdel-Halim.   

Abstract

BACKGROUND: Muscle wasting and cachexia are common occurrences in patients with chronic obstructive pulmonary disease (COPD).
OBJECTIVES: The current study aimed to investigate markers of inflammation in the circulation and skeletal muscle that might be associated with development of muscle wasting.
METHODS: Three groups of patients with mild, moderate and severe COPD and matched healthy controls were recruited. Serum levels of C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), IL-6, IL-8, TNF-alpha, cortisol, insulin-like growth factor 1 (IGF-1), leptin and ghrelin were analysed. Skeletal muscle inflammation was investigated microscopically using a panel of antibodies and standard staining for inflammatory cell infiltration.
RESULTS: All COPD patients were clinically stable, with no sign of inflammation and normal CRP values. Compared to controls, significantly increased hs-CRP levels were observed in all COPD patient groups. Significant rises in IL-6 levels were first observed in moderate COPD, while IL-8 levels were significantly elevated at the late severe stage. Circulating levels of TNF-alpha, cortisol, IGF-1, leptin and ghrelin were similar to control levels. No microscopic signs of skeletal muscle inflammation were observed.
CONCLUSION: Our results identify hs-CRP as an early marker of inflammation that is significantly increased in the circulation even in mild COPD. Serum interleukin levels appear to be increased with disease progress. These changes were manifested in the absence of any clinical signs of disease exacerbation, evidence of skeletal muscle inflammation or hormonal changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270439     DOI: 10.1159/000207793

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  19 in total

Review 1.  The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2012

2.  Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran.

Authors:  Alireza Firouzjahi; Mahmoud Monadi; Fatemeh Karimpoor; Behzad Heidari; Yahya Dankoob; Karim Hajian-Tilaki; Mokarraram Gorgani Firozjaii
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 3.  Molecular mechanism of sarcopenia and cachexia: recent research advances.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-01-19       Impact factor: 3.657

Review 4.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Nicola A Hanania; Y Michael Shim
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

Review 5.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

6.  Proteomic profiling differences in serum from silicosis and chronic bronchitis patients: a comparative analysis.

Authors:  Rongming Miao; Bangmei Ding; Yingyi Zhang; Qian Xia; Yong Li; Baoli Zhu
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

7.  A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro.

Authors:  Jeroen D Langereis; René C Schweizer; Jan-Willem J Lammers; Leo Koenderman; Laurien H Ulfman
Journal:  BMC Pulm Med       Date:  2011-09-06       Impact factor: 3.317

8.  Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.

Authors:  Matthew J Loza; Rosemary Watt; Frédéric Baribaud; Elliot S Barnathan; Stephen I Rennard
Journal:  Respir Res       Date:  2012-02-02

Review 9.  Structural alterations of skeletal muscle in copd.

Authors:  Sunita Mathur; Dina Brooks; Celso R F Carvalho
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

10.  Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammation.

Authors:  Kechun Tang; George Murano; Harrieth Wagner; Leonardo Nogueira; Peter D Wagner; Alisa Tang; Nancy D Dalton; Yusu Gu; Kirk L Peterson; Ellen C Breen
Journal:  J Appl Physiol (1985)       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.